Link Reservations/Link ResPet.com To Launch New CBD Wellness Product For People On DailylifeCBD.com
London, United Kingdom–(Newsfile Corp. – February 11, 2021) – Link Reservations, Inc./LinkResPet (OTC Pink: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces the introduction of a new CBD topical cream to its DailyLifeCBD product line. The new product, developed to soothe and relieve irritated and dry skin, will be sold through the Company’s DailyLifeCBD website, and be targeted to people, as opposed to pets.
Manufactured by its US supplier, the CBD topical cream is crafted with all-natural ingredients, including hemp, Bulgarian lavender and frankincense, and targets skin dryness and irritation. Free from parabens, dyes, and artificial fragrances, the wellness cream is compatible with all skin types.
“When we expanded into offering CBD products for people it was paramount to find a supplier that met our high standards and had the ability to scale with our anticipated growth. As with our LinkResPet division that offers high quality hemp derived CBD products for pets, we strive to provide the best CBD wellness products for pets and now people”, commented Rene Lauritsen, Link Reservations/LinkResPet CEO.
“Starting with a base product such as a CBD infused topical cream is a great first step as we venture in this new market. We look forward to placing orders in the coming months, and expanding our product offering as we identify new opportunities for growth. And, as we continue expanding our customer base and our network of suppliers such as this new partnership, we look forward to a robust 2021. We are currently working to offer other wellness products for people using compounds aside from CBD. We hope to update shareholders & the investment community accordingly”, Mr. Lauritsen added.
Link Reservations Inc./LinkResPet To Roll Out Mushroom-Infused Wellness Products
London, United Kingdom–(Newsfile Corp. – February 22, 2021) – Link Reservations Inc. (OTC PINK: LRSV) (the “Company”), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces the expansion of its DailyLifeCBD product line to include a suite of functional mushroom-infused products. The Company, having recently acquired DailyLifeCBD to enter the health and wellness sector, is looking to expand its range of complementary wellbeing products with an emphasis on natural and organic ingredients.
Due to the Covid-19 global pandemic, consumers are increasingly searching for ways to boost their immune system, seen by the market growth of alternative and complementary products. Functional (or medicinal) mushrooms possess beneficial properties such as antibacterial, anti-inflammatory and immunomodulating effects – meaning they help keep the immune system in balance. Functional mushrooms are specific varieties, such as Shiitake, Reishi, Maitake and Chaga, amongst others. According to a Market Research Future report, the global medicinal mushroom extract market is projected to register a CAGR of 6.1% and reach a value of USD 15.3 Billion by 2026, with its uses already quite varied ranging from coffee to skincare.
Having recently expanded into the health and wellness sector through its acquisition of DailyLifeCBD – a website selling CBD products for people – LRSV is now pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders.
“We are very excited and much looking forward to the opportunity for growth brought by the sale and distribution of our new premium, functional mushroom-infused suite of products. As a Company, our focus continues to be on providing high quality, natural products that can benefit the health and wellbeing of consumers,” commented Rene Lauritsen, CEO at Link Reservations Inc. “At the same time we aim to continue growing our revenue and increasing shareholder value through acquisitions and product range expansion. The LRSV team is confident of the potential that this new product suite has in enhancing the health and wellness of millions of consumers”, he added.
The Company plans to initiate activities through DailyLifeCBD with a range of non-edible lifestyle products for people and expand on the range as the site and demand grows. LRSV is considering the possibility of a subsidiary solely focused on its mushroom-infused products.
“Our expectation, based on discussions with our manufacturer, is to have these new products available for sale in the coming weeks – we are very excited by this. We will keep shareholders and the investment community updated through press releases as developments arise.”, closed Lauritsen.
Finally, if and when Federal and jurisdiction laws allow, the Company is setting its eyes on a greater prize, with a potential suite of psychedelic mushroom-infused products to follow the functional mushroom products.
Link Reservations Inc. / LinkResPet
(Stock Symbol: LRSV) is an Innovative Leader in the New, High Value Market for Pet CBD Wellness Products.
With LRSV’s price per share rising as it is beginning to gain attention, this could easily see recent highs again or greater on a low structure of only 30 million shares outstanding
Developer and Marketer of Hemp-Based CBD Pet Products.
Wholly Owned Subsidiary Operates Commercially in Europe and the US.
Company Just Returned to Fully Current Status at OTC Markets.
New Acquisition Plans Underway with Financial Backing in Place.
New Products in Development to be Launched in 2021.
Dynamic Growth Plans to Increase Revenue & Increase Shareholder Value.
Link Reservations Inc. (OTC: LRSV), based in the United Kingdom, is a pioneering CBD pet care Products Company dedicated to improving the health and life conditions of pets worldwide.
Developing and marketing hemp-based CBD pet products; LRSV currently operates in Europe and in the US. While the market for CBD pet care is expanding in the US exponentially, Europe has relatively few providers, leaving the market rife with opportunities.
According to the Brightfield Group a leading research firm that specializes in Cannabis & CBD. The pet CBD sector is expected to out perform growth wise human CBD consumption & will grow from present level of $563 million to $1.7 billion by 2025.
Pet Care Stocks are shaping up for a great 2021 with new offerings from Petco (WOOF) and BarkBox (BARK). $CHWY having record revenue Chewy CEO says pet industry trends drove 45% revenue growth, not pandemic (cnbc.com) . Amid the COVID19 pandemic pet adoption & pet ownership in Europe & U.S. has been up over 50%
Link Reservations Inc. (LSRV) will be no different!
LinkResPet.com is a wholly owned subsidiary of LRSV focused on providing and developing cannabidiol oil (CBD) & Hemp-based products for animals – primarily dogs, cats and horses.
The LRSV mission is to spread joy and health by embarking on a journey to bring a higher level of natural wellness to pets.
The material is sourced only from organically grown plants. Certified quality hemp from experienced farmers dedicated to environment-friendly farming.
LRSV products can be found under its brand www.linkrespet.com
The American Veterinarian Association reports that there is an emerging trend of pet owners using CBD and CBD products to treat the symptoms of their pets, such as nausea, seizures, anxiety, arthritis and even cancer. LRSV Products aid animals in the same ways that CBD has been shown to aid humans as well: easing the pain of arthritis, strengthening their immune systems and lessening anxiety.
A lot has been said about the usefulness of CBD products to the human body, an intensive level of research has been conducted to show how CBD can interact with the CB1 and CB2 endocannabinoid receptors to elicit their medical properties.
CBD (cannabidiol) is one of the numerous plant chemicals (cannabinoids), which have been known to elicit a wide range of medical properties such as anticancer, antidepressant, antioxidant, anti-inflammatory and antimicrobial activities.
It is the second most abundant cannabinoid after tetrahydrocannabinol (THC).
Not just in humans, the use of CBD oil for dogs, cats, and horses has been widely documented by several researchers.
Link Reservations Inc./LinkResPet (LRSV) Announces OTC Markets Current Information Reporting Standard
On December 9th LRSV announced that it is current with all of its OTC Market filings and has achieved “Current Information” status, with no risk or yields signs associated with the stock on OTCMarkets.com. LRSV has updated all financial reports and disclosure statements so that it can continue with normal operations in good standing.
LRSV also recently raised its Authorized Shares in order to issue shares to its CEO, Rene Lauritsen, for an acquisition that is pending which he initiated. These newly issued shares are restricted for one year per Rule 144 and if the acquisition is not completed the shares will be returned to treasury. As shareholders may note, the LRSV share structure had previously been unchanged for almost four years.
Sign up to get news and updates so you can be the first to know!
IMPORTANT SECURITIES DISCLAIMER:
PetCBDStock.com is a publisher owned by Corporate Ads, LLC. We have been compensated Five Thousand Dollars by LinkResPet, Inc.for the creation of this page and 1 Month advertising and dissemination of this site. We are not registered as a securities broker/dealer or an investment advisor either with the U.S. Securities and Exchange Commission or with any state securities regulatory authority. Our Service is intended to provide opinions and analysis of stocks and markets. It is not intended to provide personalized investment advice.
DO NOT E-MAIL, CALL, WRITE TO OR OTHERWISE CONTACT PetCBDStock.com SEEKING PERSONALIZED INVESTMENT ADVICE, WHICH CANNOT BE PROVIDED.
By using our Services, you understand that the material provided by our Service is for general informational purposes only. No information on this page as a part of our Service constitutes a recommendation that any particular investment, security, portfolio of securities, transaction or investment strategy is suitable for any specific person.
You further understand that PetCBDStock.com and its employees, independent contractors, affiliates, outside contributors and creators of the Services may not and will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of investments, securities, transaction, investment strategy or other matter. Accordingly, do not attempt to contact them seeking personalized investment advice, which they cannot provide.
To the extent any of the content published as part of the Service may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. The material contained within our publications should be used solely for informational purposes.
The information provided by our Service represents only our editor’s opinions and should not be relied upon for purposes of transacting securities or other investments. This information is provided by both our staff, independent contractors, affiliates and by outside contributors. While it is based on sources believed to be reliable and are written in good faith, we cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. All information should be independently verified. We are not responsible for errors or omissions in our publications, and any opinions expressed are subject to change without notice.
You bear responsibility for your own investment research, decisions and should seek the advice of a qualified securities professional before making any investment. Any sale or purchase of securities or ownership interest that results from information presented by our Service will be on a negotiated basis between you and parties other than PetCBDStock.com without any participation by or remuneration to PetCBDStock.com. You should always conduct your own research and due diligence and obtain professional advice before making any investment decision.
PetCBDStock.com will not be liable for any loss or damage caused by your reliance on information obtained in any of our publications. You are solely responsible for your own investment decisions. Before selling or buying any stock or other investment, you should consult with a qualified broker or other financial professional to verify pricing information.
PetCBDStock.com is an investment publisher, not an investment advisor. Our publications may contain information that is not accurate or complete. The opinions expressed in our publications may change without notice. We do not purport to tell you to buy or sell securities. We cannot be held accountable for any financial loss you incur by following the investment ideas in our publications. Use our research solely as a starting point for your investment decisions.
IMPORTANT DISCLAIMER CONCERNING FORWARD-LOOKING STATEMENTS:
Past results are not necessarily indicative of future performance. Understand that performance data is supplied by sources believed to be reliable, that the calculations therein are made using such data, and that such calculations are not guaranteed by these sources, the information providers, or any other person or entity, and may not be complete.
From time to time, we may make references in our marketing materials to prior articles, reports, commentary, analysis, newsletter issues and opinions we have published. These references may be selective, may reference only a portion of an article, portfolio, report, commentary, analysis, newsletter issue, opinion, or recommendation, and may not be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
We require our editorial staff and independent contractors to disclose their positions in individual securities that are mentioned in a publication that they author and that is featured on PetCBDStock.com.
IMPORTANT: Although we require our editorial staff and independent contractors to disclose their positions in individual securities that are mentioned in a publication that they author and that is featured on PetCBDStock.com, we cannot and will not guarantee that the information they disclose or fail to disclose is accurate, honest, truthful and complete.
Furthermore, we do NOT require affiliates or outside contributors to disclose their positions in individual securities that are mentioned in an article, report, commentary and analysis or newsletter issue. Therefore, our affiliates and outside contributors may write about investments or securities in which they or their firms have a position, and that they may trade for their own account and not disclose these positions to us.
In addition, portions of our Service may contain opinions that are different from other portions of our Service. PetCBDStock.com member owners, directors, employees, contract employees, independent contractors, outside contributors, subsidiaries, affiliates, advertisers, and agents may, from time to time, have long and short positions in, or buy or sell the securities, or derivatives thereof, of companies mentioned in respective Service and may take positions inconsistent with the views expressed in the Service.